Last updated: 4 September 2024 at 9:42pm EST

C. Frank Bennett Net Worth




The estimated Net Worth of C Frank Bennett is at least $4.69 millió dollars as of 1 February 2024. C Bennett owns over 1,853 units of Ionis Pharmaceuticals Inc stock worth over $3,363,230 and over the last 9 years he sold IONS stock worth over $372,704. In addition, he makes $958,865 as Chief Scientific Officer at Ionis Pharmaceuticals Inc.

C Bennett IONS stock SEC Form 4 insiders trading

C has made over 30 trades of the Ionis Pharmaceuticals Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 1,853 units of IONS stock worth $91,761 on 1 February 2024.

The largest trade he's ever made was exercising 22,805 units of Ionis Pharmaceuticals Inc stock on 9 November 2016 worth over $257,012. On average, C trades about 5,926 units every 51 days since 2016. As of 1 February 2024 he still owns at least 79,079 units of Ionis Pharmaceuticals Inc stock.

You can see the complete history of C Bennett stock trades at the bottom of the page.





C. Frank Bennett biography

Dr. C. Frank Bennett Ph.D. has been appointed as Chief Scientific Officer of the Company effective 1/1/2020. From January 2006 to December 2019, Dr. Bennett served as Senior Vice President, Antisense Research. From June 1995 to January 2006, Dr. Bennett served as our Vice President, Research. From March 1993 to June 1995, he was Director, Molecular Pharmacology, and from May 1992 to March 1993, he was an Associate Director in our Molecular and Cellular Biology department. Prior to joining Ionis in 1989, Dr. Bennett was employed by SmithKline and French Laboratories in various research positions. He is an external member of the Scientific Advisory Board of Experimental Therapeutics Center in Singapore and the Hereditary Disease Foundation.

What is the salary of C Bennett?

As the Chief Scientific Officer of Ionis Pharmaceuticals Inc, the total compensation of C Bennett at Ionis Pharmaceuticals Inc is $958,865. There are 18 executives at Ionis Pharmaceuticals Inc getting paid more, with Stanley Crooke having the highest compensation of $9,598,830.



How old is C Bennett?

C Bennett is 63, he's been the Chief Scientific Officer of Ionis Pharmaceuticals Inc since 2020. There are 12 older and 13 younger executives at Ionis Pharmaceuticals Inc. The oldest executive at Ionis Pharmaceuticals Inc is Breaux Castleman, 79, who is the Independent Director.

What's C Bennett's mailing address?

C's mailing address filed with the SEC is 2855 GAZELLE COURT, , CARLSBAD, CA, 92010.

Insiders trading at Ionis Pharmaceuticals Inc

Over the last 9 years, insiders at Ionis Pharmaceuticals Inc have traded over $32,069,332 worth of Ionis Pharmaceuticals Inc stock. The most active insiders traders include Stanley T Crooke, B Lynne Parshall és Michael R Hayden. On average, Ionis Pharmaceuticals Inc executives and independent directors trade stock every 8 days with the average trade being worth of $445,289. The most recent stock trade was executed by Richard S Geary on 28 August 2024, trading 651 units of IONS stock currently worth $32,159.



What does Ionis Pharmaceuticals Inc do?

ionis pharmaceuticals, inc., located in the north san diego county city of carlsbad, was founded in 1989 to create advanced, novel medicines to treat complex and challenging diseases. we are the pioneer in the discovery and development of antisense drugs with more than 1300 patents. ionis is a challenging, motivating and rewarding environment designed to foster innovation and scientific excellence. our founding goals have changed little in over 27 years and our success is a direct result of our outstanding employees. we are interested in bringing together individuals with different skill sets into this creative environment to be part of a productive team. join us and experience our unique culture while you develop and expand your career. for more information about ionis and to apply for an open position, please visit our website: www.ionispharma.com.



What does Ionis Pharmaceuticals Inc's logo look like?

Ionis Pharmaceuticals Inc logo

Complete history of C Bennett stock trades at Ionis Pharmaceuticals Inc

Dátum
#
Cég
Az érdekelt
Trans.
Tranzakció
Részvények száma Ár per részvény Teljes ár Részvények szíma után Forrás
1 Feb 2024 C Frank Bennett
EVP és Chief Scientific Officer
Eladás 1,853 $49.52 $91,761
1 Feb 2024
79,079
16 Jan 2024 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 18,314 $51.03 $934,563
16 Jan 2024
84,068
20 Dec 2023 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 22,613 $47.34 $1,070,499
20 Dec 2023
81,867
14 Dec 2023 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 22,612 $47.34 $1,070,452
14 Dec 2023
74,364
28 Sep 2023 C Frank Bennett
EVP és Chief Scientific Officer
Eladás 4,460 $46.50 $207,390
28 Sep 2023
65,754
3 Feb 2023 C Frank Bennett
EVP és Chief Scientific Officer
Eladás 1,813 $40.57 $73,553
3 Feb 2023
69,651
17 Jan 2023 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 19,417 $39.80 $772,797
17 Jan 2023
74,833
18 Jan 2022 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 18,842 $30.12 $567,521
18 Jan 2022
61,613
15 Jan 2021 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 15,520 $61.28 $951,066
15 Jan 2021
47,996
4 Dec 2020 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 7,947 $39.87 $316,847
4 Dec 2020
40,423
2 Dec 2020 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 7,053 $39.87 $281,203
2 Dec 2020
39,529
3 Nov 2020 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 15,000 $39.87 $598,050
3 Nov 2020
47,476
25 Jun 2020 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 15,000 $39.87 $598,050
25 Jun 2020
47,364
15 Jan 2020 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 11,711 $62.06 $726,785
15 Jan 2020
36,357
1 Feb 2019 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 9,013 $14.69 $132,401
1 Feb 2019
33,541
15 Jan 2019 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 7,822 $58.26 $455,710
15 Jan 2019
27,218
1 Nov 2018 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 12,500 $14.69 $183,625
1 Nov 2018
31,896
8 Aug 2018 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 12,500 $14.68 $183,500
8 Aug 2018
31,883
11 May 2018 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 12,500 $7.25 $90,625
11 May 2018
31,614
15 Jan 2018 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 6,663 $53.22 $354,605
15 Jan 2018
21,810
18 Oct 2017 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 12,250 $10.29 $126,053
18 Oct 2017
27,291
24 Jul 2017 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 10,000 $10.29 $102,900
24 Jul 2017
25,041
3 Mar 2017 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 5,000 $10.29 $51,450
3 Mar 2017
19,788
15 Jan 2017 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 6,195 $48.09 $297,918
15 Jan 2017
15,411
15 Jan 2017 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 6,195 $48.09 $297,918
15 Jan 2017
15,411
9 Nov 2016 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 22,805 $11.27 $257,012
9 Nov 2016
28,608
9 Nov 2016 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 22,805 $11.27 $257,012
9 Nov 2016
28,608
7 Nov 2016 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 5,000 $11.27 $56,350
7 Nov 2016
15,803
7 Nov 2016 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 5,000 $11.27 $56,350
7 Nov 2016
15,803
15 Jan 2016 C Frank Bennett
EVP és Chief Scientific Officer
Opció Gyakorlat 5,295 $43.88 $232,345
15 Jan 2016
11,112


Ionis Pharmaceuticals Inc executives and stock owners

Ionis Pharmaceuticals Inc executives and other stock owners filed with the SEC include: